6-(3-fluoro-5-propan-2-yloxyphenyl)-2-(4-methylphenyl)-N-(1H-pyrazol-5-ylsulfonyl)pyridine-3-carboxamide
C25H23FN4O4S — CID 121250954
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(3-fluoro-5-propan-2-yloxyphenyl)-2-(4-methylphenyl)-N-(1H-pyrazol-5-ylsulfonyl)pyridine-3-carboxamide
6-(3-fluoro-5-propan-2-yloxyphenyl)-2-(4-methylphenyl)-N-(1H-pyrazol-5-ylsulfonyl)pyridine-3-carboxamide (PubChem CID 121250954) has the molecular formula C25H23FN4O4S and a molecular weight of 494.55 g/mol. Its IUPAC name is 6-(3-fluoro-5-propan-2-yloxyphenyl)-2-(4-methylphenyl)-N-(1H-pyrazol-5-ylsulfonyl)pyridine-3-carboxamide.
Molecular Properties
| Compound Name | 6-(3-fluoro-5-propan-2-yloxyphenyl)-2-(4-methylphenyl)-N-(1H-pyrazol-5-ylsulfonyl)pyridine-3-carboxamide |
|---|---|
| PubChem CID | 121250954 |
| Molecular Formula | C25H23FN4O4S |
| Molecular Weight | 494.55 g/mol |
| Exact Mass | 494.14 |
| IUPAC Name | 6-(3-fluoro-5-propan-2-yloxyphenyl)-2-(4-methylphenyl)-N-(1H-pyrazol-5-ylsulfonyl)pyridine-3-carboxamide |
| SMILES | Cc1ccc(-c2nc(-c3cc(F)cc(OC(C)C)c3)ccc2C(=O)NS(=O)(=O)c2ccn[nH]2)cc1 |
| InChI | InChI=1S/C25H23FN4O4S/c1-15(2)34-20-13-18(12-19(26)14-20)22-9-8-21(24(28-22)17-6-4-16(3)5-7-17)25(31)30-35(32,33)23-10-11-27-29-23/h4-15H,1-3H3,(H,27,29)(H,30,31) |
| InChIKey | OXKNMRDTPJGYJX-UHFFFAOYSA-N |
| XLogP | 4.49 |
| TPSA | 114.04 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 494.55 |
| LogP ≤ 5 | 4.49 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121250954 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.